The Covid-19 crisis forced healthcare institutions and regulatory bodies to turn to alternative ways of providing healthcare while limiting exposure to the virus. And telemedicine is presenting itself as the ideal solution to accelerate the restart phase, encouraging the development of digital in the healthcare ecosystem.

SDG Group, in collaboration with the best experts in digital technologies and healthcare at national and international level, dedicated its best resources to a project that, starting from data, aims to limit the spread of COVID-19, by addressing the challenge of finding and monitoring potentially positive individuals, while limiting the risk of exposure of health professionals and other individuals. 

The revolutionary solution - Docdot - is an AI-assisted mobile app that allows doctors to remotely monitor a patient’s vital signs with medical grade accuracy. A patient just needs to look into their smart phone camera and answer a few questions. The results, which take as little as 45 seconds to retrieve, can be used to diagnose, monitor and ultimately prevent the spread of COVID-19 with a geo-referenced telemonitoring and televisit solution.

Designed and developed by a team of world-class telemedicine and data scientists, Docdot uses a unique combination of light signal processing and AI technologies to convert light reflected from blood vessels in your face into highly accurate real time vital sign measurements, including:

  • Heart rate (BPM)
  • Oxygen saturation (Sp02)
  • Respiration (rpm)
  • Heart Rate Variability (HRV)
  • Stress (Baesky’s and US/European Index)

"The Coronavirus emergency is giving us a new confirmation, if it were still needed, of the importance of data and Artificial Intelligence for making fast and safe decisions," comments Luca Quagini, CEO of SDG Group.

Quicker, more accurate and comprehensive than alternatives, Docdot is the first remote monitoring and triage tool with the potential to transform the diagnosis, management and treatment of those with suspected COVID-19, while helping to slow its spread.

Docdot uses light signal processing technology, or remote photoplethysmography (rPPG), a technique that enables a smart phone camera to record the light reflected by the blood vessels flowing beneath your skin. The blood volume in this micro vascular tissue varies in response to changes in respiration, blood pressure and other vital processes, allowing these variations to be converted, using proven parameters, into vital sign measurements. Independent clinical trials show over 90% of measurements to be as accurate as hospital grade monitors.

The data retrieved by Docdot is geo-referenced and collected in real-time via cloud architecture, which also enables the application of statistical-epidemiological modelling, useful for resource allocation planning and contagion forecasting.

The technology powering Docdot has been extensively tested both internally at dedicated laboratories and in independent clinical trials at General Hospital of Quebec in Canada (2020), Indira Gandhi General Hospital in India (2019), Chiba University, Japan (2019) and currently we are in progress to receiving the CE/FDA/Canada Health medical device markings (2020).  Research and testing continues with a sustained focus on achieving even higher levels of accuracy.

Jun 10, 2020